Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 21, Issue 1, 2013, Pages 237-248

  Marmotti, A ^a   Castoldi, F ^a   Rossi, R ^a   Marenco, S ^a   Risso, A ^a   Ruella, M ^a   Tron, A ^a   Borre A ^a   Blonna, D ^a   Tarella, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bone graft substitute; Bone growth; Bone marrow derived cell mobilization; G CSF; High tibial valgus osteotomy; Osseointegration

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; EQUIPMENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH STATUS INDICATOR; HUMAN; KNEE; KNEE OSTEOARTHRITIS; MALE; METHODOLOGY; MIDDLE AGED; OSTEOTOMY; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDY; RADIOGRAPHY; STEM CELL MOBILIZATION; TIBIA; TREATMENT OUTCOME; VARUS KNEE;

ADULT; AGED; BONE SUBSTITUTES; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GENU VARUM; GRANULOCYTE COLONY-STIMULATING FACTOR; HEALTH STATUS INDICATORS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSSEOINTEGRATION; OSTEOARTHRITIS, KNEE; OSTEOTOMY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84871918842     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-012-2150-z     Document Type: Article

References (62)

1. Aalderink KJ, Shaffer M, Amendola A (2010) Rehabilitation following high tibial osteotomy. Clin Sports Med 29: 291-301.
2. Anderlini P (2009) Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol 16: 35-40.
3. Anderlini P, Champlin RE (2008) Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111: 1767-1772.
4. Baldo MP, Davel APC, Damas-Souza DM, Nicoletti-Carvalho JE, Bordin S, Carvalho HF, Rodrigues SL, Rossoni LV, Mill JG (2011) The antiapoptotic effect of granulocyte colony-stimulating factor reduces infarct size and prevents heart failure development in rats. Cell Physiol Biochem 28: 33-40.
5. Bozlar M, Aslan B, Kalaci A, Baktiroglu L, Yanat AN, Tasci A (2005) Effects of human granulocyte-colony stimulating factor on fracture healing in rats. Saudi Med J 26: 1250-1254.
6. Brouard N, Driessen R, Short B, Simmons PJ (2010) G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption. Stem Cell Res 5: 65-75.
7. Cesselli D, Beltrami AP, Rigo S, Bergamin N, D'Aurizio F, Verardo R, Piazza S, Klaric E, Fanin R, Toffoletto B, Marzinotto S, Mariuzzi L, Finato N, Pandolfi M, Leri A, Schneider C, Beltrami CA, Anversa P (2009) Multipotent progenitor cells are present in human peripheral blood. Circ Res 104: 1225-1234.
8. Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES (1997) Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 15: 368-377.
9. Chen Y, Jiang X, Gong J (2008) Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi. J Vasc Surg 47: 1058-1065.
10. Chiò A, Mora G, La Bella V, Caponnetto C, Mancardi G, Sabatelli M, Siciliano G, Silani V, Corbo M, Moglia C, Calvo A, Mutani R, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Bondesan P, Garbelli S, Mantovani S, Bendotti C, Tarella C (2011) Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve 43: 189-195.
11. Cho S-W, Lim JE, Chu HS, Hyun H-J, Choi CY, Hwang K-C, Yoo KJ, Kim D-I, Kim B-S (2006) Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A 76: 252-263.
12. Dallari D, Savarino L, Stagni C, Cenni E, Cenacchi A, Fornasari PM, Albisinni U, Rimondi E, Baldini N, Giunti A (2007) Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89: 2413-2420.
13. Ekmekçi OB, Oztürk G, Ekmekçi H, Atay D, Yanaşik M, Anak S, Devecioǧlu O (2009) Effects of rhG-CSF plus dexamethasone on hemostatic parameters in healthy granulocyte donors: role of u-PA and nitric oxide. Clin Appl Thromb Hemost 15: 689-694.
14. Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C (2006) Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 45: 13-19.
15. Gangji V, Hauzeur J-P, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A: 1153-1160.
16. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK (2012) Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142(3): 505-512. e1.
17. Haas R, Murea S (1995) The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells. Cytokines Mol Ther 1: 249-270.
18. Hack M, Mascha FG, Jobst BJ, Riegger GAJ, Griese DP (2008) A systemic combination therapy with granulocyte-colony stimulating factor plus erythropoietin aggravates the healing process of balloon-injured rat carotid arteries. Cardiovasc Drugs Ther 22: 351-362.
19. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A (2009) Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 94: 94-101.
20. Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, Livingston DH (2011) Impact of enhanced mobilization of bone marrow derived cells to site of injury. J Trauma 71: 283-291.
21. Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E (1997) Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 126: 600-607.
22. Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H (2006) Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 88(Suppl 1 Pt 2): 322-327.
23. Ince H, Valgimigli M, Petzsch M, de Lezo JS, Kuethe F, Dunkelmann S, Biondi-Zoccai G, Nienaber CA (2008) Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis. Heart 94: 610-616.
24. Ishida K, Matsumoto T, Sasaki K, Mifune Y, Tei K, Kubo S, Matsushita T, Takayama K, Akisue T, Tabata Y, Kurosaka M, Kuroda R (2010) Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A 16: 3271-3284.
25. Jäger M, Jelinek EM, Wess KM, Scharfstädt A, Jacobson M, Kevy SV, Krauspe R (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4: 34-43.
26. Kaptan K, Ifran A, Beyan C, Sertkaya D (2007) Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation. Hematology 12: 441-444.
27. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37: 967-976.
28. Kastrup J, Ripa RS, Wang Y, Jørgensen E (2006) Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Eur Heart J 27: 2748-2754.
29. Kaygusuz MA, Turan CC, Aydin NE, Temel I, Firat S, Bulut T, Kuku I (2006) The effects of G-CSF and naproxen sodium on the serum TGF-beta1 level and fracture healing in rat tibias. Life Sci 80: 67-73.
30. Klocke R, Kuhlmann MT, Scobioala S, Schäbitz W-R, Nikol S (2008) Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Curr Med Chem 15: 968-977.
31. Kocher MS, Steadman JR, Briggs KK, Sterett WI, Hawkins RJ (2004) Reliability, validity, and responsiveness of the Lysholm knee scale for various chondral disorders of the knee. J Bone Joint Surg Am 86-A: 1139-1145.
32. Kuroda R, Matsumoto T, Miwa M, Kawamoto A, Mifune Y, Fukui T, Kawakami Y, Niikura T, Lee SY, Oe K, Shoji T, Kuroda T, Horii M, Yokoyama A, Ono T, Koibuchi Y, Kawamata S, Fukushima M, Kurosaka M, Asahara T (2010) Local transplantation of G-CSF-mobilized CD34+cells in a patient with tibial nonunion: a case report. Cell Transplant.
33. Lian WS, Lin H, Cheng WT, Kikuchi T, Cheng CF (2011) Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy. J Biomed Sci 18: 26.
34. Liongue C, Wright C, Russell AP, Ward AC (2009) Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 41: 2372-2375.
35. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, Mastrogiacomo M, Cancedda R (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
36. Marenco S, Bellato E, Marini E, Mortera S, Castoldi F, Borré A, Castellano S, La Russa M, Marmotti A, Cottino U (2011) The role of CT and DEXA in the evaluation of biomaterial HATriC graft osseointegration in high tibial osteotomy. Minerva Ortopedica e Traumatologica Agosto 62(4): 45-239.
37. Martino M, Luise F, Oriana V, Console G, Moscato T, Mammì C, Messina G, Massara E, Irrera G, Piromalli A, Lombardo VT, Laganà C, Iacopino P (2007) Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cells. Tumori 93: 155-159.
38. Matsumoto T, Kawamoto A, Kuroda R, Ishikawa M, Mifune Y, Iwasaki H, Miwa M, Horii M, Hayashi S, Oyamada A, Nishimura H, Murasawa S, Doita M, Kurosaka M, Asahara T (2006) Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169: 1440-1457.
39. Mifune Y, Matsumoto T, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Kwon S-M, Miwa M, Kurosaka M, Asahara T (2008) Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells 26: 1395-1405.
40. Moioli EK, Clark PA, Chen M, Dennis JE, Erickson HP, Gerson SL, Mao JJ (2008) Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3: e3922.
41. Naina HV, Pruthi RK, Inwards DJ, Dingli D, Litzow MR, Ansell SM, William HJ, Dispenzieri A, Buadi FK, Elliott MA, Gastineau DA, Gertz MA, Hayman SR, Johnston PB, Lacy MQ, Micallef IN, Porrata LF, Kumar S (2011) Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization. Bone Marrow Transplant 46: 291-293.
42. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL (2009) Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the national marrow donor program. Blood 113: 3604-3611.
43. Quillen K, Byrne P, Yau YY, Leitman SF (2009) Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone. Transfusion 49: 513-518.
44. Sasaki K, Kuroda R, Ishida K, Kubo S, Matsumoto T, Mifune Y, Kinoshita K, Tei K, Akisue T, Tabata Y, Kurosaka M (2008) Enhancement of tendon-bone osteointegration of anterior cruciate ligament graft using granulocyte colony-stimulating factor. Am J Sports Med 36: 1519-1527.
45. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347: 353-357.
46. Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG (2011) Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am 93: 1057-1063.
47. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339: 640-644.
48. Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH (2009) Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res 31: 167-172.
49. Solaroglu I, Jadhav V, Zhang JH (2007) Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 12: 712-724.
50. Spiel AO, Bartko J, Schwameis M, Firbas C, Siller-Matula J, Schuetz M, Weigl M, Jilma B (2011) Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost 105: 655-662.
51. Spiel AO, Siller-Matula J, Firbas C, Leitner JM, Russmueller G, Jilma B (2010) Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans. Platelets 21: 464-469.
52. Takano H, Ohtsuka M, Akazawa H, Toko H, Harada M, Hasegawa H, Nagai T, Komuro I (2003) Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 9: 1121-1127.
53. Tarella C, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Moglia C, Ulla M, Omedé P, Bella VL, Corbo M, Silani V, Siciliano G, Mora G, Caponnetto C, Sabatelli M, Chiò A (2010) Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy 12: 50-59.
54. Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H, Taniuchi S, Kaneko K, Adachi Y, Ikehara S (2008) Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J 72: 1351-1358.
55. Terayama H, Ishikawa M, Yasunaga Y, Yamasaki T, Hamaki T, Asahara T, Ochi M (2011) Prevention of osteonecrosis by intravenous administration of human peripheral blood-derived CD34-positive cells in a rat osteonecrosis model. J Tissue Eng Regen Med 5(1): 32-40.
56. Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL (2007) Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the research on adverse drug events and reports project. Bone Marrow Transplant 40: 185-192.
57. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct 4 expression, and plasticity. Stem Cells 23: 1105-1112.
58. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
59. Wu X, Yang S, Duan D, Liu X, Zhang Y, Wang J, Yang C, Jiang S (2008) A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits. J Rheumatol 35: 2241-2248.
60. Wu Y-D, Chien C-H, Chao YJ, Hamrick MW, Hill WD, Yu JC, Li X (2008) Granulocyte colony-stimulating factor administration alters femoral biomechanical properties in C57BL/6 mice. J Biomed Mater Res A 87: 972-979.
61. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, Proya E, Anagnostopoulos A, Fassas A (2005) G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33: 108-119.
62. Zhang Y, Wang L, Fu Y, Song H, Zhao H, Deng M, Zhang J, Fan D (2009) Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10: 430-431.